SFX by Ex Libris Inc.

Title:	Utilization of biotinylated diphenyl phosphonates for disclosure of serine proteases
Source:	Analytical Biochemistry [0003-2697] Hawthorne, Susan yr:2004

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Curtis, T. "Mueller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products." Diabetologia 54.3 (2011): 690-.
description	2.	Leung, D. "Protease inhibitors: current status and future prospects." Journal of medicinal chemistry 43.3 (2000): 305-41.
description	3.	Hamilton, R. "Synthesis and proteinase inhibitory properties of diphenyl phosphonate analogs of aspartic and glutamic acids." Bioorganic and medicinal chemistry letters 8.13 (1998): 1655-.
description	4.	Abbenante, G. "Protease inhibitors in the clinic." Medicinal chemistry 1.1 (2004): 71-104.
description	5.	Zhou, Q. "Viral caspase inhibitors CrmA and p35." Methods in enzymology 322: 143-154.
description	6.	Babine, R.E. E. "Molecular recognition of protein-ligand complexes: Applications to drug design." Chemical reviews 97.5 (1997): 1359-1472.
description	7.	Funovics, M. "Protease sensors for bioimaging." Analytical and bioanalytical chemistry 377.6 (2003): 956-963.
description	8.	PERONA, J. "STRUCTURAL BASIS OF SUBSTRATE-SPECIFICITY IN THE SERINE PROTEASES." Protein science 4.3 (1995): 337-360.
description	9.	Perona, J. "Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold." The Journal of biological chemistry 272.48 (1997): 29987-29990.
description	10.	Crespo, L. "Peptide and amide bond-containing dendrimers." Chemical reviews 105.5 (2005): 1663-1681.
description	11.	Wagner, Brian D. "A visual demonstration of supramolecular chemistry: observable fluorescence enhancement upon host-guest inclusion." Journal of chemical education 77.2 (2000): 178-181.
description	12.	Weissleder, R. "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes." Nature biotechnology 17.4 (1999): 375-378.
description	13.	Rockwell, W G R. "Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia." The Prostate 48.1 (2001): 16-28.
description	14.	Bochtler, M. "The proteasome." Annual review of biophysics and biomolecular structure 28.1 (1999): 295-317.
description	15.	Rawlings, N D D. "Families of serine peptidases." Methods in enzymology 244: 19-61.
description	16.	Mann, M. "Trypsin cleaves exclusively C-terminal to arginine and lysine residues." Molecular & cellular proteomics 3.6 (2004): 608-14.
description	17.	De, E. "Antiviral drugs in current clinical use." Journal of clinical virology 30.2 (2004): 115-33.
description	18.	Njoroge, F. "Challenges in modern drug discovery: a case study of boceprevir, an HCV pro tease inhibitor for the treatment of hepatitis C virus infection." Accounts of chemical research 41.1 (2008): 50-59.
description	19.	Boehm, H. "What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs?" Angewandte Chemie. International edition in English 35.22 (1996): 2588-2614.
description	20.	Terpe, K. "Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems." Applied microbiology and biotechnology 60.5 (2003): 523-533.